SP110 Nuclear Body Protein (SP110) (Middle Region) Peptide
SP110
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits SP110
- SP110 (SP110 Nuclear Body Protein (SP110))
- Protein Region
- Middle Region
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-SP110 antibody (Catalog #: ARP36126_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- SP110 (SP110 Nuclear Body Protein (SP110))
- Synonymes
- SP110 Peptide, IFI41 Peptide, IFI75 Peptide, IPR1 Peptide, VODI Peptide, 5031415C07Rik Peptide, 52kDa Peptide, 5830484A20Rik Peptide, ENSMUSG00000075603 Peptide, Ifi75 Peptide, Ipr1 Peptide, SP110 nuclear body protein Peptide, Sp110 nuclear body protein Peptide, SP110 Peptide, Sp110 Peptide
- Sujet
-
The nuclear body is a multiprotein complex that may have a role in the regulation of gene transcription. SP110 is a member of the SP100/SP140 family of nuclear body proteins and is a leukocyte-specific nuclear body component. The protein can function as a
Alias Symbols: FLJ22835, IFI41, IFI75, VODI, IPR1
Protein Interaction Partner: NDUFV2,NDUFV2
Protein Size: 713 - Poids moléculaire
- 81 kDa
- ID gène
- 3431
- NCBI Accession
- NM_080424, NP_536349
-
Vous êtes ici:
